Drug industry takes great care to be responsible healthcare partnerBMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6695 (Published 26 October 2011) Cite this as: BMJ 2011;343:d6695
- Stephen Whitehead, chief executive1
- 1Association of the British Pharmaceutical Industry, London SW1E 6QT, UK
Heath questions the appropriateness of drug companies providing support for meetings and events on the subject of public health.1
Companies strive to operate within the Association of the British Pharmaceutical Industry’s code of practice to ensure that the sponsorship of meetings is appropriate. Sanctions are punitive for those who do not comply.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial